Latest News

Attendance at the European Chemistry Partnering (ECP) Event

inSEIT Showcases Innovation and Expands Its Network at SLUSH 2024

inSEIT was at CPHI - The Leading Pharmaceutical Event

Attendance at the Swiss Chemical Society (SCS) Fall Meeting: Presenting inSEIT’s In Silico Design for Enzyme Immobilization

The Venture committee recognizes inSEIT's innovative potential in transforming the chemical industry

Road to Boston - inSEIT selected as one of the 10 start-ups to participate in the Venture Leaders Biotech 2024

We closed our first financing round, supported by Value Maker and VentureLabs. Together with the non-dilutive funding from Innosuisse and Bridge (Bridge Proof of Concept) and the support from the Berninvest we raised over CHF 390K.

inSEIT selected to participate in an open innovation innitiative by Johnson Matthey and The Bakery

David Roura, our CEO, is awarded a Proof of concept grant for a total amount of CHF 129K

inSEIT was selected as one of the winners of the Stage II from the Venturekick competition, organized by VentureLabs.

inSEIT selected as one of the finalist for the Ypsomed Award

Scientific Excellence and Novel Idea Award for inSEIT in the first edition of the Nucleate Activator in Switzerland.

The Bern Economic Development Agency supports novel and promising start-ups based in the Berner Oberland.